Concepedia

Publication | Open Access

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

317

Citations

27

References

2015

Year

Abstract

Imetelstat was found to be active in patients with myelofibrosis but also had the potential to cause clinically significant myelosuppression. (Funded by Geron; ClinicalTrials.gov number, NCT01731951.).

References

YearCitations

Page 1